Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study
- E. Bruckert, G. Hayem, S. Dejager, C. Yau, B. Bégaud
- Medicine
- Cardiovascular Drugs and Therapy
- 1 December 2005
SummaryObjectives: To characterize the risk factors, rate of occurrence, onset, nature and impact of mild to moderate muscular symptoms with high-dosage HMG-CoA reductase inhibitor (statin) therapy… Expand
Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia.
- Stéphane Picard, K. Titier, +10 authors F. Mahon
- Medicine
- Blood
- 15 April 2007
Using high-performance liquid chromatography-tandem mass spectrometry, we assessed trough imatinib plasma levels in 68 patients with chronic myeloid leukemia (CML) who responded or not to… Expand
Use of oral corticosteroids in the United Kingdom.
- T. V. van Staa, H. Leufkens, L. Abenhaim, B. Bégaud, B. Zhang, C. Cooper
- Medicine
- QJM : monthly journal of the Association of…
- 1 February 2000
Administration of oral corticosteroids is associated with the development of osteoporosis and an increased risk of fractures. However, the size of the treated sub-population who would benefit from… Expand
Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of…
- J. Dequeker, C. Hawkey, +8 authors S. Papazoglou
- Medicine
- British journal of rheumatology
- 1 September 1998
SELECT is a large-scale, prospective, international, multicentre, double-blind, double-dummy, randomized, parallel-group trial. Patients with exacerbation of osteoarthritis were treated with the… Expand
Admissions to hospital caused by adverse drug reactions: cross sectional incidence study
- P. Pouyanne, F. Haramburu, J. Imbs, B. Bégaud
- Medicine
- BMJ : British Medical Journal
- 15 April 2000
The incidence of adverse reactions to drugs has been assessed with prospective epidemiological studies conducted within single units, departments, or hospitals.1–3 Because of the variability of the… Expand
Patterns and correlates of benzodiazepine use in the French general population
- R. Lagnaoui, F. Depont, +4 authors N. Moore
- Medicine
- European Journal of Clinical Pharmacology
- 28 August 2004
ObjectiveTo investigate the prevalence of current use of benzodiazepines (BZDs) and related drugs in the French general population and factors associated with this use.Methods National… Expand
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.
- L. Abenhaim, Y. Moride, +9 authors B. Bégaud
- Medicine
- The New England journal of medicine
- 29 August 1996
BACKGROUND
Recently, a cluster of patients was observed in France in whom primary pulmonary hypertension developed in patients exposed to derivatives of fenfluramine in appetite suppressants… Expand
Benzodiazepine use and risk of Alzheimer’s disease: case-control study
- Sophie Billioti de Gage, Y. Moride, +5 authors B. Bégaud
- Medicine
- BMJ : British Medical Journal
- 9 September 2014
Objectives To investigate the relation between the risk of Alzheimer’s disease and exposure to benzodiazepines started at least five years before, considering both the dose-response relation and… Expand
Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.
- C. Hawkey, A. Kahan, +8 authors S. Papazoglou
- Medicine
- British journal of rheumatology
- 1 September 1998
Although widely used, non-steroidal anti-inflammatory drugs (NSAIDs) are associated with a high incidence of gastrointestinal (GI) side-effects. Inhibition of the cyclooxygenase (COX) enzyme is the… Expand